pharmaphorum Podcast

Turning drug development on its head

In this instalment of the pharmaphorum podcast, host Jonah Comstock welcomes Alchemab CEO Young Kwon, whose company has a different approach: starting with the healthiest of individuals and studying them to find out why they aren’t sick. Specifically, they’re looking through large data sets of healthy and disease-resistant people and looking for common antibodies that could help us all fight disease.

GLP-1 Weight loss drugs: An overview and update

On today’s pharmaphorum podcast, Dr. Tim Church, chief medical officer at digital weight loss clinic Wondr Health joins Editor in Chief Jonah Comstock to chat about these new drugs, how they work, and how they're changing the game for patients.

Biopharma’s rapid transition to omnichannel marketing

In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions at Advanz Pharma and Mokhtar Elsayed, head of global go to market commercial transformation at Sanofi.  

Partnering for holistic care

In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strategy at Medisafe. Both companies specialise in digital health and, although different, entered into a partnership at the end of June.

Mapping the landscape of clinical trial regulation

In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs and what’s currently lacking.

Preparing for the tsunami of healthcare data approaching

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on healthcare.

Alzheimer’s drugs: An overview and update

In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks about the need for a holistic approach to Alzhemier’s treatment and the importance of lifestyle changes and early detection in fully addressing this devastating disease.  
 

Suffering beyond physical effects: inequalities and taboos in prostate cancer

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo).

Collaborative perseverance to bring change to medicine access

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex).

Botanicals in pharma: Potential and pitfalls

In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new category.